y 27632 has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achilefu, S; Alhallak, K; Azab, AK; Azab, F; de la Puente, P; DiPersio, JF; Duncan, K; Federico, C; Guenthner, N; Gurley, S; Hallahan, DE; Kapoor, V; King, J; Kohnen, D; Kotsybar, J; Markovic, M; Muz, B; Salama, NN; Sudlow, GP; Sun, J; Thotala, D; Vij, R; Wasden, K; Yuan, F; Zhang, L | 1 |
| Fujishima, Y; Ishida, Y; Ito, S; Kowata, S; Murai, K; Shimoyama, T; Yashima-Abo, A | 1 |
2 other study(ies) available for y 27632 and Multiple Myeloma
| Article | Year |
|---|---|
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma.
Topics: Amides; Animals; Apoptosis; Bortezomib; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Focal Adhesion Protein-Tyrosine Kinases; Human Umbilical Vein Endothelial Cells; Humans; Liposomes; Membrane Glycoproteins; Mice; Multiple Myeloma; Nanoparticles; P-Selectin; Protein Binding; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Signal Transduction; src-Family Kinases; Tumor Burden; Tumor Microenvironment | 2020 |
Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
Topics: Amides; Animals; Antineoplastic Agents; Blood Platelets; Bone Marrow; Boronic Acids; Bortezomib; Colony-Forming Units Assay; Disease Models, Animal; Male; Megakaryocyte Progenitor Cells; Megakaryocytes; Mice; Multiple Myeloma; Platelet Count; Pyrazines; Pyridines; rho-Associated Kinases; Thrombocytopenia; Thrombopoiesis; Thrombopoietin | 2014 |